The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2016
Filed:
Feb. 08, 2013
Applicant:
Velicept Therapeutics, Inc., Malvern, PA (US);
Inventors:
Stephen Caltabiano, King of Prussia, PA (US);
Eliot Ohlstein, Glenmoore, PA (US);
Stewart McCallum, King of Prussia, PA (US);
Assignee:
Velicept Therapeutics, Inc., Malvern, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/135 (2006.01); A01N 33/02 (2006.01); A01N 33/00 (2006.01); A61K 31/13 (2006.01); A61K 31/16 (2006.01); A01N 43/04 (2006.01); A61K 31/70 (2006.01); A61K 31/216 (2006.01); A61K 31/7024 (2006.01); A61K 31/196 (2006.01); A61K 31/426 (2006.01); A61K 45/06 (2006.01); A61K 31/137 (2006.01); A61K 31/357 (2006.01); A61K 31/4725 (2006.01); A61K 31/351 (2006.01);
U.S. Cl.
CPC ...
A61K 31/216 (2013.01); A61K 31/137 (2013.01); A61K 31/196 (2013.01); A61K 31/351 (2013.01); A61K 31/357 (2013.01); A61K 31/426 (2013.01); A61K 31/4725 (2013.01); A61K 31/7024 (2013.01); A61K 45/06 (2013.01);
Abstract
Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.